Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Depression, Endogenous

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Depression, Endogenous in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bennett, SA; Fai, S; Herrmann, N; Lanctôt, KL; Mazereeuw, G; Swardfager, W; Valenzuela, N; Xu, H1
Adler, L; Baker, N; Christiano, J; Daniell, LC; Dubovsky, SL; Franks, RD; Harris, RA; Murphy, J1

Reviews

1 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Depression, Endogenous

ArticleYear
Platelet activating factors in depression and coronary artery disease: a potential biomarker related to inflammatory mechanisms and neurodegeneration.
    Neuroscience and biobehavioral reviews, 2013, Volume: 37, Issue:8

    Topics: Animals; Biomarkers; Blood Platelets; Coronary Artery Disease; Depressive Disorder; Humans; Inflammation; Nerve Degeneration; Oxidative Stress; Platelet Activating Factor; Signal Transduction

2013

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Depression, Endogenous

ArticleYear
Increased platelet intracellular calcium concentration in patients with bipolar affective disorders.
    Archives of general psychiatry, 1989, Volume: 46, Issue:7

    Topics: Adult; Antidepressive Agents; Bipolar Disorder; Blood Platelets; Calcium; Depressive Disorder; Electroconvulsive Therapy; Female; Humans; Male; Middle Aged; Platelet Activating Factor; Thrombin

1989